). R. mannitolilytica can be distinguished from all described Ralstonia species by its acidification of D-arabitol and mannitol and by its lack of nitrate reduction and of alkalinization of tartrate. In order to determine the true prevalence of infections with this species, colistin-resistant "P. fluorescens" strains and strains growing on B. cepacia selective medium deserve further attention.
and the patient was referred to the Ghent University Hospital for removal of the endovascular catheter segment. Cultures of the removed catheter were positive and were identified as Ralstonia pickettii biovar 3/"thomasii." Retrospectively, it was shown that this was also the correct identification for the "P. fluorescens" isolates that had been obtained from the private hospital. The strain was resistant to ampicillin, gentamicin, temocillin, and aztreonam but was susceptible to cotrimoxazole, piperacilin, cefuroxime, cefotaxime, ceftazidime, imipenem, and quinolones. The patient was treated, according to the susceptibility testing results, with cotrimoxazole and doxycycline. Since then, the patient has been doing well.
Case report 2. In December 1997, primary cholangiocarcinoma with extensive hepatic involvement was diagnosed in a 32-year-old woman. Chemotherapy with cis-platinum and 5-fluoroacil was started with good clinical response and improvement of the hepatic lesions. Six months later, the patient was seen in the surgery department for partial resection of the liver in order to reduce the tumor mass and to improve the effect of chemotherapy. One week after the resection, computerized axial tomography (CAT) scanning revealed that the Kehr drain was leaking into the abdomen. A hemoperitoneum was diagnosed, and a review of the abdomen revealed bleeding of the right vena subhepatica. Intraoperatively, a specimen was taken from the hematoma for culture. After enrichment in thioglycolate broth, Enterococcus sp. and a gram-negative nonfermenting bacillus were isolated. Three days after review, the patient developed fever with peaks up to 39°C and antibiotherapy with cefuroxime was started. Abdominal drainage fluid culture yielded the same gram-negative nonfermenter. This strain was resistant to ampicillin, gentamicin, colimycin, and temocillin but susceptible to cotrimoxazole, cefuroxime, and quinolones. Despite cefuroxime treatment, fever persisted and metronidazole was added. A CAT scan of the abdomen showed an excessive amount of free abdominal fluid. One week later, small numbers of the nonfermenter and of Enterococcus sp. could still be isolated from the abdominal drainage fluid. Antibiotherapy was switched to piperacillin and tazobactam, and a new abdominal drain was placed. As the patient remained febrile, drug fever was suspected and antibiotics were stopped. A subsequent fluid specimen again grew Enterococcus sp. and a gram-negative, nonfermenting bacillus, later identified as R. mannitolilytica. The patient's condition improved very slowly, and finally the patient was discharged from the hospital knowing that new intrahepatic lesions were detected on CAT scan.
Strain LMG 19090, obtained from patient 1, was isolated on conventional media and could grow on Burkholderia cepacia selective medium, containing 100 mg of ticarcillin/liter and 300 U of polymyxin B/ml. API 20NE (BioMérieux, Marcy l'Etoile, France) testing identified the strain as P. fluorescens (profile code 0 054 555). Because of colistin resistance, this strain was studied in more detail (3, 7, 13, 14) , which led to an identification as R. pickettii biovar 3/"thomasii."
The further data gathered by means of polyphasic taxonomy led to the description of this biovar as a separate species, named R. mannitolilytica, referring to its characteristic acidification of mannitol, unlike all other described Ralstonia species (5). The original spelling of the specific epithet "mannitolytica" (5) was corrected to "mannitolilytica" (8) .
In retrospect, strain LMG 19091 from patient 2, which had been identified previously as P. fluorescens (API 20NE profile code 0 045 555), and strain LMG 6866
T , isolated at St. Thomas' Hospital (London, United Kingdom) during an outbreak and deposited as "Pseudomonas thomasii" in 1972 (NCIB 10805) (11, 12) , could both be identified as R. mannitolilytica.
The GϩC content for all three R. mannitolilytica strains tested was 66.2 mol%, which is higher than the values for R. pickettii (64.0 to 64.1%) (5) . The 16S rDNA sequences of the clinical strains (GenBank accession numbers AJ270256 and AJ270257) were identical and clustered at more than 99.5% sequence similarity with the R. mannitolilytica type strain LMG
6866
T (GenBank accession number AJ270258) (5). The 16S rDNA sequences for the R. pickettii biovar Va-1 and Va-2 strains clustered at 96% similarity versus R. mannitolilytica. DNA hybridization confirmed that the two clinical strains and the type strain belonged to a separate species (5). When tRNA PCR was performed (1, 9), all three strains had a PCR fragment of 108.4 bp (standard deviation, 0.06 bp), in combination with one or two other variably present fragments. The obtained tRNA PCR fingerprints were sufficiently discriminative for us to recognize each strain as being R. mannitolilytica.
The two clinical R. mannitolilytica strains were motile by a single polar flagellum, while motility was not observed for the culture collection R. mannitolilytica type strain LMG 6866
T . It was observed that freshly isolated strains were very motile and that motility decreased upon prolonged preservation and subculture, which could explain the nonmotility of the type strain. All three strains grew at 30, 37, and 42°C and were viable for less than 6 days on tryptic soy agar (Becton Dickinson, Cockeysville, Md.) at 25°C. Oxidase and catalase were positive. They were resistant to desferrioxamine, O:129, and colistin. No acid was produced from ethylene glycol. Urease, pyrrolidonyl arylamidase (Rosco, Taastrup, Denmark), Tween esterase, and phenylalanine deaminase were positive. Acid was oxidatively produced from glucose, L-arabinose, lactose, maltose, mannitol, D-arabitol, and D-xylose. Alkalinization occurred on minimal mineral agar with acetate, serine, malonate, ␤-alanine, 4-aminobutyrate, azelate, succinate, fumarate, butyrate, formate, malate, mucate, galacturonate, citrate, histidine, and lactate but not with acetamide, adipate, alginate, allantoin, amygdalin, L-arginine, benzoate, L-ornithine, maleate, and tartrate (5).
In the routine clinical laboratory, R. mannitolilytica can be differentiated from P. fluorescens and Pseudomonas aeruginosa by a negative pyoverdin test, by its inability to grow on salmonella-shigella agar, and by a negative arginine dihydrolase test (Table 1) . Growth on B. cepacia selective medium pointed to an identification as B. cepacia. Differentiation from B. cepacia, especially from the genomovar II strains (i.e., Burkholderia multivorans), which do not decarboxylate lysine or acidify su- 
Reduction of nitrate
a ND, not done; ϩ/Ϫ, majority of strains positive; Ϫ/ϩ, majority of strains negative; R, resistant; S, susceptible, and V, variable. b Trypsin ϭ benzyl arginine arylamidase.
crose (15) , is difficult and is only possible by means of a positive pyrrolidonyl arylamidase test for R. mannitolilytica. Finally, several clear phenotypic differences exist between R. mannitolilytica and the other Ralstonia species (Table 1) . R. mannitolilytica can be differentiated from the other described Ralstonia species through its assimilation and acidification of mannitol and D-arabitol. R. mannitolilytica strains differ from R. pickettii and Ralstonia solanacearum by their resistance towards desferrioxamine and from R. pickettii because of their lack of alkalinization of tartrate and of nitrate reductase. Strains of R. mannitolilytica were previously reported to be adonitol and ethanol acidification negative, like the R. pickettii biovars Va-1 and Va-2, and cellobiose positive, like R. pickettii biovar Va-1 (13) .
A limited number of cases of hospital outbreaks with "P. thomasii" and R. pickettii biovar 3/"thomasii" isolates have been reported in the literature (2, 6, 10, 11) . The first report (12) dealt with bacteremia and bacteriuria in 25 patients due to parenteral fluids prepared with deionized water contaminated with "P. thomasii" (11, 12) . Pan et al. (10) reported that 23 of 39 R. pickettii isolates of an epidemic involving 24 patients that was caused by contaminated saline solution (prepared by the hospital pharmacy) belonged to "P. thomasii." A pseudo-outbreak has been described as well (4) . Although no serious non-outbreak-related infections have been described thus far, the clinical importance of R. mannitolilytica may have been overlooked, possibly due to misidentification as P. fluorescens, B. multivorans, and/or R. pickettii.
We reported two cases of infection with R. mannitolilytica, first identified as P. fluorescens and/or B. cepacia. Colistinresistant "P. fluorescens" isolates and strains growing on B. cepacia selective medium should be considered to be possibly R. mannitolilytica, a species that was formerly known as R. pickettii biovar 3/"thomasii" and that can be differentiated from P. fluorescens by its colistin resistance and its absence of arginine dihydrolase activity, from B. cepacia and B. multivorans by its pyrrolidonyl peptidase activity, and from other Ralstonia species by the acidification of mannitol. Correct identification of this organism may be of importance, since appropriate treatment was postponed in at least case 1, due to misidentification as P. fluorescens and B. cepacia, pointing to the presence of a contaminant and also obscuring the long-term presence of the same bacterial organism.
